Page last updated: 2024-08-23

10-carboxymethyl-9-acridanone and Hepatitis B, Chronic

10-carboxymethyl-9-acridanone has been researched along with Hepatitis B, Chronic in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frolov, VM; Kozlov, VK; Oyungerel, M; Romantsov, MG; Shul'diakov, AA; Sologub, TV; Stel'makh, VV; Tuan, NKh1
Chiriukina, OI; MalyÄ­, VP; Pen'kov, DV1
Agaeva, SG; Goriacheva, LG; Kovalenko, AL; Lin'kov, IuN; Romantsov, MG1
Goriacheva, LG; Kovalenko, AL; Lin'kova, IuN; Romantsov, MG; Shul'diakov, AA; Sologub, TV1
Baranova, IP; Goriacheva, LG; Kovalenko, AL; Lin'kova, IuN; Romantsov, MG; Shul'diakov, AA; Sologub, TV1
Stel'makh, VV1
Alekseeva, LA; Bessonova, TV; Goriacheva, LG; Kotiv, MIa; Romantsov, MG; Vasil'eva, DK1

Reviews

1 review(s) available for 10-carboxymethyl-9-acridanone and Hepatitis B, Chronic

ArticleYear
[Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2010, Volume: 55, Issue:5-6

    Topics: Acridines; Antiviral Agents; Child; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferon Inducers; Interferon-alpha; Recurrence

2010

Trials

3 trial(s) available for 10-carboxymethyl-9-acridanone and Hepatitis B, Chronic

ArticleYear
[Comparative efficacy of etiotropic therapy of patients with HBeAg-positive chronic hepatitis B (by the data of the international comparative placebo-controlled study)].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2013, Volume: 58, Issue:9-10

    Topics: Acridines; Adult; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Hepatocytes; Humans; Interferon Inducers; Lamivudine; Male; Reverse Transcriptase Inhibitors; Time Factors

2013
[Chemotherapy of chronic viral hepatitis B: randomized multicenter investigation results].
    Eksperimental'naia i klinicheskaia farmakologiia, 2010, Volume: 73, Issue:11

    Topics: Acridines; Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon Inducers; Lamivudine; Male; Remission Induction

2010
[Cycloferon efficacy of therapy of chronic hepatitis B (results of randomized multicentre study)].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2010, Volume: 55, Issue:9-10

    Topics: Acridines; Administration, Oral; Adult; Drug Therapy, Combination; Hepatitis B virus; Hepatitis B, Chronic; Humans; Injections, Intramuscular; Interferon Inducers; Lamivudine; Reverse Transcriptase Inhibitors; Russia; Treatment Outcome

2010

Other Studies

3 other study(ies) available for 10-carboxymethyl-9-acridanone and Hepatitis B, Chronic

ArticleYear
[Cycloferon therapy of acute and chronic virus hepatitis C].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2013, Volume: 58, Issue:9-10

    Topics: Acridines; Adolescent; Adult; Dose-Response Relationship, Drug; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon Inducers; Male

2013
[Possibilities of using interferon-induction therapy during latent HBV infection].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:5

    Topics: Acridines; Adult; Antiviral Agents; Biopsy, Needle; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunity, Cellular; Immunotherapy; Interferon alpha-2; Interferon Inducers; Interferon Type I; Interferon-alpha; Leukocytes, Mononuclear; Liver; Male; Phagocytes; Recombinant Proteins; Virus Latency

2011
[Minimization of endogenous intoxication syndrome by individual choice of drugs for therapy of chronic hepatitis].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:3-4

    Topics: Acridines; Adolescent; Antiviral Agents; Asymptomatic Infections; Biomarkers; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon Inducers; Interferon-alpha; Ribavirin; Treatment Outcome

2011